152 related articles for article (PubMed ID: 22612225)
1. Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2.
Sun H; Lee CM; Tripathi S; Kim KB; Morgan ET
Biochem J; 2012 Aug; 445(3):377-82. PubMed ID: 22612225
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins.
Lee CM; Kim BY; Li L; Morgan ET
J Biol Chem; 2008 Jan; 283(2):889-98. PubMed ID: 17993647
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-regulated proteolysis of human CYP2B6 via the ubiquitin-proteasome system.
Lee CM; Tripathi S; Morgan ET
Free Radic Biol Med; 2017 Jul; 108():478-486. PubMed ID: 28427998
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes.
Sewer MB; Morgan ET
Biochem Pharmacol; 1997 Sep; 54(6):729-37. PubMed ID: 9310350
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, in primary cultures of rat hepatocytes.
Ferrari L; Peng N; Halpert JR; Morgan ET
Mol Pharmacol; 2001 Jul; 60(1):209-16. PubMed ID: 11408616
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of phenobarbital-induced cytochrome P4502B mRNAs and proteins by endotoxin in mice: independence from nitric oxide production by inducible nitric oxide synthase.
Li-Masters T; Morgan ET
Biochem Pharmacol; 2002 Dec; 64(12):1703-11. PubMed ID: 12445859
[TBL] [Abstract][Full Text] [Related]
7. Roles of nitric oxide in inflammatory downregulation of human cytochromes P450.
Aitken AE; Lee CM; Morgan ET
Free Radic Biol Med; 2008 Mar; 44(6):1161-8. PubMed ID: 18206661
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and interleukin-1β stimulate the proteasome-independent degradation of the retinoic acid hydroxylase CYP2C22 in primary rat hepatocytes.
Lee CM; Lee BS; Arnold SL; Isoherranen N; Morgan ET
J Pharmacol Exp Ther; 2014 Jan; 348(1):141-52. PubMed ID: 24144795
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of immunoproteasome reduces infarction volume and attenuates inflammatory reaction in a rat model of ischemic stroke.
Chen X; Zhang X; Wang Y; Lei H; Su H; Zeng J; Pei Z; Huang R
Cell Death Dis; 2015 Jan; 6(1):e1626. PubMed ID: 25633295
[TBL] [Abstract][Full Text] [Related]
10. Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia.
Du SH; Xiang YJ; Liu L; Nie M; Hou Y; Wang L; Li BB; Xu M; Teng QL; Peng J; Hou M; Shi Y
Front Immunol; 2020; 11():603278. PubMed ID: 33552061
[TBL] [Abstract][Full Text] [Related]
11. Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures.
Lee CM; Pohl J; Morgan ET
Drug Metab Dispos; 2009 Apr; 37(4):865-72. PubMed ID: 19171675
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the proteasome in IL-1beta induced suppression of islets of Langerhans in the rat.
Sternesjö J; Karlsen AE; Sandler S
Ups J Med Sci; 2003; 108(1):37-50. PubMed ID: 12903836
[TBL] [Abstract][Full Text] [Related]
13. Ethylbenzene induces microsomal oxygen free radical generation: antibody-directed characterization of the responsible cytochrome P450 enzymes.
Serron SC; Dwivedi N; Backes WL
Toxicol Appl Pharmacol; 2000 May; 164(3):305-11. PubMed ID: 10799341
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells.
Kotamraju S; Matalon S; Matsunaga T; Shang T; Hickman-Davis JM; Kalyanaraman B
Free Radic Biol Med; 2006 Mar; 40(6):1034-44. PubMed ID: 16540399
[TBL] [Abstract][Full Text] [Related]
15. The activity of cytochrome P450 CYP2B in rat liver during neuroleptic treatment.
Haduch A; Wójcikowski J; Daniel WA
Pharmacol Rep; 2007; 59(5):606-12. PubMed ID: 18048963
[TBL] [Abstract][Full Text] [Related]
16. Quantitative PCR assay for cytochromes P450 2B and 3A induction in rat precision-cut liver slices: correlation study with induction in vivo.
Cui X; Thomas A; Han Y; Palamanda J; Montgomery D; White RE; Morrison RA; Cheng KC
J Pharmacol Toxicol Methods; 2005; 52(2):234-43. PubMed ID: 16125621
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic beta-cells: involvement of glycogen synthase kinase-3beta.
Tanioka T; Tamura Y; Fukaya M; Shinozaki S; Mao J; Kim M; Shimizu N; Kitamura T; Kaneki M
J Biol Chem; 2011 Aug; 286(33):29388-29396. PubMed ID: 21700708
[TBL] [Abstract][Full Text] [Related]
18. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1796-802. PubMed ID: 9812920
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation by dexamethasone of fluvastatin-inducible CYP2B expression in primary cultures of rat hepatocytes: role of CYP3A.
Kocarek TA; Reddy AB
Biochem Pharmacol; 1998 May; 55(9):1435-43. PubMed ID: 10076536
[TBL] [Abstract][Full Text] [Related]
20. Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11.
Nikolova-Karakashian M; Morgan ET; Alexander C; Liotta DC; Merrill AH
J Biol Chem; 1997 Jul; 272(30):18718-24. PubMed ID: 9228043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
